TANDEM DIABETES CARE INC (TNDM) Stock Fundamental Analysis

NASDAQ:TNDM • US8753722037

24.57 USD
+6.05 (+32.67%)
At close: Feb 20, 2026
24.58 USD
+0.01 (+0.04%)
After Hours: 2/20/2026, 8:07:44 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TNDM. TNDM was compared to 185 industry peers in the Health Care Equipment & Supplies industry. TNDM has a bad profitability rating. Also its financial health evaluation is rather negative. TNDM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • TNDM had negative earnings in the past year.
  • TNDM had a negative operating cash flow in the past year.
  • In the past 5 years TNDM reported 4 times negative net income.
  • In multiple years TNDM reported negative operating cash flow during the last 5 years.
TNDM Yearly Net Income VS EBIT VS OCF VS FCFTNDM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

  • TNDM has a Return On Assets (-23.25%) which is in line with its industry peers.
  • Looking at the Return On Equity, with a value of -152.95%, TNDM is doing worse than 68.11% of the companies in the same industry.
Industry RankSector Rank
ROA -23.25%
ROE -152.95%
ROIC N/A
ROA(3y)-14.09%
ROA(5y)-9.07%
ROE(3y)-42.99%
ROE(5y)-26.95%
ROIC(3y)N/A
ROIC(5y)N/A
TNDM Yearly ROA, ROE, ROICTNDM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

  • With a Gross Margin value of 53.23%, TNDM perfoms like the industry average, outperforming 49.73% of the companies in the same industry.
  • TNDM's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for TNDM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.92%
GM growth 5Y-0.58%
TNDM Yearly Profit, Operating, Gross MarginsTNDM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • TNDM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TNDM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TNDM Yearly Shares OutstandingTNDM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
TNDM Yearly Total Debt VS Total AssetsTNDM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of 0.33, we must say that TNDM is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.33, TNDM perfoms like the industry average, outperforming 49.19% of the companies in the same industry.
  • A Debt/Equity ratio of 2.37 is on the high side and indicates that TNDM has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 2.37, TNDM is doing worse than 83.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.37
Debt/FCF N/A
Altman-Z 0.33
ROIC/WACCN/A
WACC9.28%
TNDM Yearly LT Debt VS Equity VS FCFTNDM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 2.44 indicates that TNDM has no problem at all paying its short term obligations.
  • TNDM's Current ratio of 2.44 is in line compared to the rest of the industry. TNDM outperforms 49.19% of its industry peers.
  • A Quick Ratio of 1.90 indicates that TNDM should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.90, TNDM perfoms like the industry average, outperforming 51.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 1.9
TNDM Yearly Current Assets VS Current LiabilitesTNDM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for TNDM have decreased by -0.97% in the last year.
EPS 1Y (TTM)-0.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.74%

3.2 Future

  • Based on estimates for the next years, TNDM will show a very strong growth in Earnings Per Share. The EPS will grow by 23.79% on average per year.
  • The Revenue is expected to grow by 8.78% on average over the next years. This is quite good.
EPS Next Y33.35%
EPS Next 2Y35.43%
EPS Next 3Y29.63%
EPS Next 5Y23.79%
Revenue Next Year10.28%
Revenue Next 2Y9.8%
Revenue Next 3Y9.57%
Revenue Next 5Y8.78%

3.3 Evolution

TNDM Yearly Revenue VS EstimatesTNDM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
TNDM Yearly EPS VS EstimatesTNDM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -5 -10 -15 -20 -25

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TNDM. In the last year negative earnings were reported.
  • Also next year TNDM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNDM Price Earnings VS Forward Price EarningsTNDM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNDM Per share dataTNDM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • TNDM's earnings are expected to grow with 29.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.43%
EPS Next 3Y29.63%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • TNDM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TANDEM DIABETES CARE INC

NASDAQ:TNDM (2/20/2026, 8:07:44 PM)

After market: 24.58 +0.01 (+0.04%)

24.57

+6.05 (+32.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-19
Earnings (Next)04-28
Inst Owners115.78%
Inst Owner Change0.19%
Ins Owners0.72%
Ins Owner Change4.63%
Market Cap1.67B
Revenue(TTM)N/A
Net Income(TTM)-203.37M
Analysts72.67
Price Target24.9 (1.34%)
Short Float %13.32%
Short Ratio6.72
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.74%
Min EPS beat(2)-18.66%
Max EPS beat(2)3.18%
EPS beat(4)2
Avg EPS beat(4)20.77%
Min EPS beat(4)-18.66%
Max EPS beat(4)104.27%
EPS beat(8)5
Avg EPS beat(8)15.83%
EPS beat(12)5
Avg EPS beat(12)-40.04%
EPS beat(16)5
Avg EPS beat(16)-129.71%
Revenue beat(2)1
Avg Revenue beat(2)1.01%
Min Revenue beat(2)-1.1%
Max Revenue beat(2)3.12%
Revenue beat(4)3
Avg Revenue beat(4)4.09%
Min Revenue beat(4)-1.1%
Max Revenue beat(4)9.97%
Revenue beat(8)6
Avg Revenue beat(8)4.19%
Revenue beat(12)6
Avg Revenue beat(12)1.79%
Revenue beat(16)8
Avg Revenue beat(16)1.24%
PT rev (1m)5.71%
PT rev (3m)19.6%
EPS NQ rev (1m)-1.26%
EPS NQ rev (3m)7.29%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)11.07%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-2.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.65
P/FCF N/A
P/OCF N/A
P/B 12.53
P/tB 12.53
EV/EBITDA N/A
EPS(TTM)-1.46
EYN/A
EPS(NY)-0.98
Fwd EYN/A
FCF(TTM)-1.05
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS14.85
BVpS1.96
TBVpS1.96
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -23.25%
ROE -152.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.23%
FCFM N/A
ROA(3y)-14.09%
ROA(5y)-9.07%
ROE(3y)-42.99%
ROE(5y)-26.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.92%
GM growth 5Y-0.58%
F-Score4
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 2.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 360.22%
Cap/Sales 6.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.44
Quick Ratio 1.9
Altman-Z 0.33
F-Score4
WACC9.28%
ROIC/WACCN/A
Cap/Depr(3y)341.43%
Cap/Depr(5y)300.44%
Cap/Sales(3y)6.42%
Cap/Sales(5y)5.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y33.35%
EPS Next 2Y35.43%
EPS Next 3Y29.63%
EPS Next 5Y23.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.74%
Revenue Next Year10.28%
Revenue Next 2Y9.8%
Revenue Next 3Y9.57%
Revenue Next 5Y8.78%
EBIT growth 1Y34.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year53.91%
EBIT Next 3Y43.18%
EBIT Next 5Y30.57%
FCF growth 1Y-47.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.98%
OCF growth 3Y-39.87%
OCF growth 5Y-10.38%

TANDEM DIABETES CARE INC / TNDM FAQ

What is the ChartMill fundamental rating of TANDEM DIABETES CARE INC (TNDM) stock?

ChartMill assigns a fundamental rating of 2 / 10 to TNDM.


What is the valuation status of TANDEM DIABETES CARE INC (TNDM) stock?

ChartMill assigns a valuation rating of 1 / 10 to TANDEM DIABETES CARE INC (TNDM). This can be considered as Overvalued.


How profitable is TANDEM DIABETES CARE INC (TNDM) stock?

TANDEM DIABETES CARE INC (TNDM) has a profitability rating of 1 / 10.